Clinical Trial Update: Pilot Study to Assess Safety/Preliminary Effectiveness of Prefix in Subjects With Degenerative Disc Disease (DDD) Undergoing Spine Fusion Surgery [Phase 1, Phase 2]

View source ↗

Summary

Pilot Phase 1/2 study to assess the safety and preliminary effectiveness of Prefix in subjects with degenerative disc disease undergoing spine fusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease
• Spondylolisthesis

Drugs mentioned

• Prefix

Snippet

Sponsor: BioSurface Engineering Technologies, Inc | Conditions: Degenerative Disc Disease, Spondylolisthesis | Phase 1, Phase 2 | Status: UNKNOWN